Sign In
Buy CERT
$8.10
+0.320 (+4.11%)
At Close: Jul 31, 2026
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
04:30pm, Thursday, 30'th Sep 2021
Cloud-based and validated regulatory software automates and advances quality of patient narratives Cloud-based and validated regulatory software automates and advances quality of patient narratives
Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long Term
04:10am, Wednesday, 29'th Sep 2021
Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long Term
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
08:00am, Wednesday, 22'nd Sep 2021
Multi-Disciplinary Expansion and New Appointments Grow Capacity and Capabilities Multi-Disciplinary Expansion and New Appointments Grow Capacity and Capabilities
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
08:00am, Monday, 20'th Sep 2021
Represents Fourth FDA Grant for Simcyp MechDermA™ Model for Virtual Bioequivalence Represents Fourth FDA Grant for Simcyp MechDermA™ Model for Virtual Bioequivalence
PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common st
CERT Stock: Why It Is Trading Lower Today
11:00am, Thursday, 09'th Sep 2021
The stock price of Certara Inc (NASDAQ: CERT) dropped over 7% pre-market this morning. This is why it happened.
Certara Stock Under Pressure On Equity Raise Of $140M At 12% Discount
06:32am, Thursday, 09'th Sep 2021
Certara Inc (NASDAQ: CERT) has priced its previously announced underwritten public offering of 4.5 million shares at $31.00 per share for gross proceeds of $139.5 million. The offer price represent
Certara Announces Pricing of Public Offering of Common Stock
09:01pm, Wednesday, 08'th Sep 2021
PRINCETON, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of shares of its com
Certara Announces Proposed Public Offering of Common Stock
06:10am, Friday, 03'rd Sep 2021
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its
Certara to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 31'st Aug 2021
PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the fo
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call Transcript
04:26pm, Saturday, 07'th Aug 2021
Certara Inc's (CERT) CEO William Feehery on Q2 2021 Results - Earnings Call Transcript
Certara To Buy Compliance Software Provider For $310; Q2 Earnings Beat Expectations, Raises FY21 Guidance
08:11am, Friday, 06'th Aug 2021
Certara Inc (NASDAQ: CERT) has agreed to acquire Pinnacle 21 for $310 million in cash and stock. Pinnacle 21's software tools are used to validate compliance to the Clinical Data Interchange Sta
Certara Reports Second Quarter 2021 Financial Results
04:20pm, Thursday, 05'th Aug 2021
Raises full year 2021 guidance and announces deal to acquire Pinnacle 21 Raises full year 2021 guidance and announces deal to acquire Pinnacle 21
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data
04:15pm, Thursday, 05'th Aug 2021
Transaction expected to be accretive to Certara's revenue, revenue growth and adjusted EBITDA margin Transaction expected to be accretive to Certara's revenue, revenue growth and adjusted EBITDA margi
Mubadala Invests in Global Biosimulation Leader Certara
05:03pm, Tuesday, 27'th Jul 2021
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately $250
